Structure, function, and mechanism of cytosolic quinone reductases

被引:25
作者
Bianchet, Mario A. [1 ]
Erdemli, Sabri Bora [1 ]
Amzel, L. Mario. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21202 USA
来源
VITAMIN K | 2008年 / 78卷
关键词
D O I
10.1016/S0083-6729(07)00004-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Quinone reductases type 1 (QR1) are FAD-containing enzymes that catalyze the reduction of many quinones, including menadione (Vit K3), to hydroquinones using reducing equivalents provided by NAD(P)H. The reaction proceeds with a ping-pong mechanism in which the NAD(P)H and the substrate occupy alternatively overlapping regions of the same binding site and participate in a double hydride transfer: one from NAD(P)H to the FAD of the enzyme, and one from the FADH(2) of the enzyme to the quinone substrate. The main function of QR1 is probably the detoxification of dietary quinones but it may also contribute to the reduction of vitamin K for its involvement in blood coagulation. In addition, the same reaction that QR1 uses in the detoxification of quinones, activates some compounds making them cytotoxic. Since QR1 is elevated in many tumors, this property has encouraged the development of chemotherapeutic compounds that become cytotoxic after reduction by QR1. The structures of QR1 alone, and in complexes with substrates, inhibitors, and chemotherapeutic prodrugs, combined with biochemical and mechanistic studies have provided invaluable insight into the mechanism of the enzyme as well as suggestions for the improvements of the chemotherapeutic prodrugs. Similar information is beginning to accumulate about another related enzyme, QR2. (C) 2008 Elsevier Inc.
引用
收藏
页码:63 / +
页数:25
相关论文
共 86 条
[1]
Binding of the anticancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex [J].
AbuKhader, M ;
Heap, J ;
De Matteis, C ;
Kellam, B ;
Doughty, SW ;
Minton, N ;
Paoli, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7714-7719
[2]
AMZEL LM, 1986, J BIOL CHEM, V261, P1379
[3]
BAYNEY RM, 1987, J BIOL CHEM, V262, P572
[4]
INCREASED SENSITIVITY OF QUINONE RESISTANT CELLS TO MITOMYCIN-C [J].
BEGLEITER, A ;
ROBOTHAM, E ;
LACEY, G ;
LEITH, MK .
CANCER LETTERS, 1989, 45 (03) :173-176
[5]
BEGLEITER A, 1988, CANCER RES, V48, P1727
[6]
Begleiter A, 2004, METHOD ENZYMOL, V382, P320
[7]
BENATTI U, 1987, CHEM SCRIPTA, V27A, P169
[8]
THE DIFFERENCES IN KINETICS OF RAT AND HUMAN DT DIAPHORASE RESULT IN A DIFFERENTIAL SENSITIVITY OF DERIVED CELL-LINES TO CB-1954 (5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE) [J].
BOLAND, MP ;
KNOX, RJ ;
ROBERTS, JJ .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (6-7) :867-875
[9]
REDOX AND ADDITION CHEMISTRY OF QUINOID COMPOUNDS AND ITS BIOLOGICAL IMPLICATIONS [J].
BRUNMARK, A ;
CADENAS, E .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 7 (04) :435-477
[10]
Crystal structure of quinone reductase 2 in complex with resveratrol [J].
Buryanovskyy, L ;
Fu, Y ;
Boyd, M ;
Ma, YL ;
Hsieh, TC ;
Wu, JM ;
Zhang, ZT .
BIOCHEMISTRY, 2004, 43 (36) :11417-11426